Adriamycin-induced modulation of host defenses in tumor-bearing mice

Using the C57BL/6/EL4 tumor model, studies were carried out to demonstrate the feasibility of administering Adriamycin (ADM) in therapeutic doses and schedules such that the host antitumor defenses would not be suppressed and in some cases might be stimulated by treatment. ADM treatment caused prolo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 1992-07, Vol.52 (13), p.3572-3576
Hauptverfasser:	MACCUBBIN, D. L, WING, K. R, MACE, K. F, HO, R. L. X, EHRKE, M. J, MIHICH, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic agents Biological and medical sciences Chemotherapy Doxorubicin - pharmacology Female Medical sciences Mice Mice, Inbred C57BL Neoplasms, Experimental - immunology Pharmacology. Drug treatments T-Lymphocytes, Cytotoxic - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!